Ben Armitage

Ben Armitage is a shareholder and CEO of Billion & Armitage. He advises clients across the full spectrum of intellectual property law, with particular depth in patents and trademarks, and he is increasingly active in the firm’s growing litigation practice following the addition of experienced trial counsel.

Ben’s practice spans transactional and strategic counseling—guiding clients on patent procurement, portfolio management, licensing, and infringement matters—while also supporting litigation strategy as the firm expands into contested IP proceedings.

He has extensive technical experience in the medical device, cleantech, and chemical industries, as well as instrumentation, biofuels, biomass conversion, fuel cells, batteries, polymers, catalysts, nanotechnology, sensors, animal health, crop science, and sporting goods technologies. His background in chemistry and device development allows him to work seamlessly across disciplines, including mechanical and process engineering.

In addition to his legal practice, Ben is a recognized leader in the field of artificial intelligence. He counsels clients on patenting AI technologies and has presented on the intersection of AI, intellectual property, and law.

Ben earned his B.A. in Chemistry (magna cum laude) from Central College, his M.S. in Analytical Chemistry from the University of Iowa—where he conducted interdisciplinary research on non-invasive medical detection devices—and his J.D. from the University of Minnesota.